Telix Pharmaceuticals partners with QDOSE and ABX-CRO to integrate QDOSE dosimetry software into therapeutic radiopharmaceutical programs.

Telix Pharmaceuticals partners with QDOSE and ABX-CRO to commercially integrate the QDOSE dosimetry software platform into therapeutic radiopharmaceutical programs. QDOSE is a versatile software platform that allows for reliable estimation of patient-specific dosimetry for both therapeutic and diagnostic radiopharmaceuticals. This collaboration aims to develop personalised treatment regimens, optimizing treatment response while minimizing effects on healthy organs and streamlining isotope supply chains.

March 18, 2024
13 Articles